Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vitrafy Life SciencesASX:VFY -0.71%5 Current Ratio is 13.47 as of Dec. 2025, which is 49% below its 10-year median of 26.60. GuruFocus rates ASX:VFY with a GF Score™ of 5/100. The stock has 5 warning signs investors should review. Among 2,875 Software companies, Vitrafy Life Sciences ranks better than 97.15% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Vitrafy Life Sciences's current ratio for the quarter that ended in Dec. 2025 was 13.47.
Vitrafy Life Sciences has a current ratio of 13.47. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Vitrafy Life Sciences's Current Ratio or its related term are showing as below:
ASX:VFY'
s Current Ratio Range Over the Past 10 Years
Min: 11.47 Med: 26.6 Max: 47.98
Current: 13.47
During the past 4 years, Vitrafy Life Sciences's highest Current Ratio was 47.98. The lowest was 11.47. And the median was 26.60.
ASX:VFY's Current Ratio is ranked better than 97.15% of 2875
companies
in the Software industry
Industry Median: 1.81
vs ASX:VFY: 13.47
Vitrafy Life Sciences (ASX:VFY) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Vitrafy Life Sciences Current Ratio Related Terms
Vitrafy Life Sciences Current Ratio Historical Data
* Premium members only.
The historical data trend for Vitrafy Life Sciences's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:VFY vs MSFT, ORCL, PLTR: Current Ratio Comparison
For the Software - Infrastructure subindustry, Vitrafy Life Sciences's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vitrafy Life Sciences Current Ratio vs Software Industry
For the Software industry and Technology sector, Vitrafy Life Sciences's Current Ratio distribution charts can be found below:
* The bar in red indicates where Vitrafy Life Sciences's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vitrafy Life Sciences (ASX:VFY) has a Current Ratio of 13.47 as of Dec. 2025. This is 49% below median its historical median of 26.60. Over the past decade, Vitrafy Life Sciences' Current Ratio has ranged from 11.47 to 47.98. According to the industry distribution chart, Vitrafy Life Sciences ranks #82 out of 2875 companies in the Software industry, placing it in the top 2.9%.
Is Vitrafy Life Sciences' Current Ratio too high?
Vitrafy Life Sciences' current Current Ratio of 13.47 is 49% below median its 10-year median of 26.60. Over the past 10 years, this metric has ranged from a low of 11.47 to a high of 47.98. The Software industry median Current Ratio is 1.81. Vitrafy Life Sciences' value of 13.47 is 644.2% above this industry median. Based on the distribution chart, Vitrafy Life Sciences ranks #82 out of 2875 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Vitrafy Life Sciences has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Vitrafy Life Sciences' Current Ratio compare to MSFT and ORCL?
According to the Software industry distribution chart, Vitrafy Life Sciences ranks #82 out of 2875 companies for Current Ratio. This places Vitrafy Life Sciences in the top 3% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.81. Vitrafy Life Sciences' value of 13.47 is 644.2% above this benchmark. Historically, Vitrafy Life Sciences' own Current Ratio has ranged from 11.47 to 47.98 over the past decade. While the company's 10-year median is 26.60 vs. the industry median of 1.81, Vitrafy Life Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Software company?
The median Current Ratio among Software companies is 1.81, based on 2,875 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vitrafy Life Sciences's current Current Ratio of 13.47 is 644.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Software industry, the median Current Ratio is 1.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitrafy Life Sciences's current Current Ratio is 13.47, which is 49% below median its own 10-year median of 26.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitrafy Life Sciences stock overvalued right now?
Vitrafy Life Sciences (ASX:VFY) has a current Current Ratio of 13.47. The current Current Ratio is 13.47, which is 49% below median its 10-year median of 26.60 and 644.2% above the Software industry median of 1.81. Vitrafy Life Sciences' overall GF Score™ is 5/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Vitrafy Life Sciences (ASX:VFY), the current Current Ratio is 13.47 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vitrafy Life Sciences Ltd developed a range of proprietary smart cryopreservation hardware devices and Lifechain, an integrated, cloud-based software platform, to provide a complete, vertically integrated cryopreservation solution to retain the quality of cryopreserved biomaterials. The company devices includes Vitrafy's Smart Cryopreservation Device; Vitrafy's Smart Thawing Device and Vitrafy's Smart Packaging.
5GF Score
Get the complete analysis for ASX:VFY
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:VFY has been successfully added to your 
